We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$24.3B
AUM Growth
+$1.52B
(+6.7%)
Cap. Flow
+$416M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
19.48%
Holding
1,977
New
232
Increased
535
Reduced
722
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$298M |
| 2 |
Spotify
SPOT
|
+$249M |
| 3 |
NVIDIA
NVDA
|
+$230M |
| 4 |
Cardinal Health
CAH
|
+$129M |
| 5 |
Vipshop
VIPS
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amdocs
DOX
|
+$125M |
| 2 |
Crane NXT
CXT
|
+$114M |
| 3 |
Deutsche Bank
DB
|
+$96M |
| 4 |
Qiagen
QGEN
|
+$92.3M |
| 5 |
Arista Networks
ANET
|
+$83.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Healthcare | 13.93% |
| 3 | Consumer Staples | 11.94% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
951
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $754K | ﹤0.01% |
868,620
-183,098
| -17% | -$131K |
|
|
952
Qiagen
QGEN
$9.05B
| $752K | ﹤0.01% |
15,846
-1,914,863
| -99% | -$92.3M |
|
953
Foster
FSTR
$414M
| $750K | ﹤0.01% |
52,593
+11,174
| +27% | +$138K |
|
954
Eaton
ETN
$173B
| $744K | ﹤0.01% |
3,710
-21,924
| -86% | -$3.86M |
|
955
Bausch Health
BHC
$2.37B
| $743K | ﹤0.01% |
92,854
-79,300
| -46% | -$585K |
|
|
FOCL
956
EDAP TMS S.A.
FOCL
$228M
| $741K | ﹤0.01% |
81,024
-203,026
| -71% | -$2.08M |
|
957
Johnson Controls International
JCI
$91.3B
| $740K | ﹤0.01% |
10,886
-24,930
| -70% | -$1.53M |
|
958
CoStar Group
CSGP
$12.8B
| $737K | ﹤0.01% |
+8,294
| New | +$640K |
|
|
SY
959
So-Young International
SY
$228M
| $736K | ﹤0.01% |
401,008
+177,267
| +79% | +$425K |
|
|
KZR
960
DELISTED
Kezar Life Sciences
KZR
| $729K | ﹤0.01% |
29,793
+28,341
| +1,952% | +$738K |
|
961
Riskified
RSKD
$712M
| $726K | ﹤0.01% |
150,864
+60,336
| +67% | +$303K |
|
962
Haemonetics
HAE
$3.94B
| $724K | ﹤0.01% |
8,504
-7,743
| -48% | -$655K |
|
|
PPLI
963
People Inc
PPLI
$3.03B
| $723K | ﹤0.01% |
14,094
+12,356
| +711% | +$566K |
|
|
LONA
964
LeonaBio Inc
LONA
$70.5M
| $721K | ﹤0.01% |
24,482
-12,210
| -33% | -$348K |
|
965
Southern Missouri Bancorp
SMBC
$842M
| $715K | ﹤0.01% |
18,640
-8,781
| -32% | -$323K |
|
|
HT
966
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $715K | ﹤0.01% |
117,585
-250,202
| -68% | -$1.54M |
|
|
MPT
967
Medical Properties Trust
MPT
$2.48B
| $712K | ﹤0.01% |
76,985
+64,174
| +501% | +$543K |
|
|
MRC
968
DELISTED
MRC Global
MRC
| $712K | ﹤0.01% |
70,743
-433,762
| -86% | -$4.1M |
|
969
DXC Technology
DXC
$1.74B
| $708K | ﹤0.01% |
26,503
+24,789
| +1,446% | +$617K |
|
970
Spectrum Brands
SPB
$2.02B
| $704K | ﹤0.01% |
9,035
+9,029
| +150,483% | +$644K |
|
971
Royal Caribbean
RCL
$82.4B
| $703K | ﹤0.01% |
6,781
| – | – |
|
972
Ferrari
RACE
$71.5B
| $702K | ﹤0.01% |
2,154
+989
| +85% | +$288K |
|
|
TRIB
973
Trinity Biotech
TRIB
$8.91M
| $701K | ﹤0.01% |
4,853
-97
| -2% | -$14.1K |
|
974
AMC Global Media
AMCX
$489M
| $697K | ﹤0.01% |
58,361
+54,737
| +1,510% | +$790K |
|
975
Lamar Advertising Co
LAMR
$15.7B
| $695K | ﹤0.01% |
7,019
-10,596
| -60% | -$1.03M |
|
Similar funds
Acadian Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Acadian Asset Management held 1,977 positions worth $24.3B, up 6.7% from $22.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Acadian Asset Management's Q2 2023 filing shows 232 new, 535 increased, 722 reduced and 249 closed positions. Its largest new stake was Indivior Pharmaceuticals: 2,328,706 shares worth $54M. The largest sale was Amdocs, an estimated $125M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.
- Acadian Asset Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 2,328,706 shares worth $54M.
- Acadian Asset Management added most to Alphabet (Google) Class A in Q2 2023, an estimated $298M increase.
- Acadian Asset Management's biggest Q2 2023 reduction was Crane NXT, cutting an estimated $114M.
- Acadian Asset Management fully exited Amdocs in Q2 2023, selling an estimated $125M.
- Acadian Asset Management's ten largest holdings make up 19% of its $24.3B portfolio in Q2 2023.
- Acadian Asset Management opened 232 new positions and closed 249 in Q2 2023.
- Acadian Asset Management's portfolio value rose 6.7% quarter-over-quarter to $24.3B.
Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.